UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2010-02, Vol.8 (2), p.237-242

2010

Volltextzugriff (PDF)

Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk

Journal of thrombosis and haemostasis, 2015-05, Vol.13 (5), p.782-787

2015

Volltextzugriff (PDF)

Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial

Lupus, 2016-03, Vol.25 (3), p.301-306

2016

Volltextzugriff (PDF)

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile

Journal of thrombosis and haemostasis, 2013-08, Vol.11 (8), p.1527-1531

2013

Volltextzugriff (PDF)

APS - Diagnostics and challenges for the future

Autoimmunity reviews, 2016-11, Vol.15 (11), p.1031-1033

2016

Volltextzugriff (PDF)

Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs)

Thrombosis research, 2018-03, Vol.163, p.100-104

2018

Volltextzugriff (PDF)

Laboratory testing for antiphospholipid syndrome

International journal of laboratory hematology, 2016-05, Vol.38 (S1), p.27-31

2016

Volltextzugriff (PDF)

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)

Thrombosis research, 2010-08, Vol.126 (2), p.150-153

2010

Volltextzugriff (PDF)

Antiphospholipid syndrome: critical analysis of the diagnostic path

Lupus, 2010-04, Vol.19 (4), p.428-431

2010

Volltextzugriff (PDF)

Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study

Journal of thrombosis and thrombolysis, 2013-02, Vol.35 (2), p.178-184

2013

Volltextzugriff (PDF)

Correct laboratory approach to APS diagnosis and monitoring

Autoimmunity reviews, 2013-06, Vol.12 (8), p.832-834

2013

Volltextzugriff (PDF)

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles

Thrombosis research, 2015-07, Vol.136 (1), p.161-163

2015

Volltextzugriff (PDF)

458Real world persistence with direct oral anticoagulants in anticoagulation naive patients with atrial fibrillation

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

Antiphospholipid syndrome: antibodies to Domain 1 of [beta]2-glycoprotein 1 correctly classify patients at risk

Journal of thrombosis and haemostasis, 2015-05, Vol.13 (5), p.782

2015

Volltextzugriff (PDF)

Quantitative analysis of mitral valve geometry by transthoracic three-dimensional echocardiography: accuracy, feasibility, reproducibility and reference values

European heart journal, 2013-08, Vol.34 (suppl 1), p.5863-5863

2013

Volltextzugriff (PDF)

Long-term use of vitamin K antagonists in patients with atrial fibrillation and cancer incidence: a pharmaco-epidemiological study

European heart journal, 2013-08, Vol.34 (suppl 1), p.P2735-P2735

2013

Volltextzugriff (PDF)

Oral Abstract session New insights in heart muscle diseases: 13/12/2013, 16:30-18:00 Location: Bursa

European heart journal cardiovascular imaging, 2013-12, Vol.14 (suppl 2), p.ii133-ii134

2013

Volltextzugriff (PDF)

Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study

European heart journal cardiovascular imaging, 2018-06, Vol.19 (6), p.630-638

2018

Volltextzugriff (PDF)

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study

Blood, 2011-10, Vol.118 (17), p.4714-4718

2011

Volltextzugriff (PDF)

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

Blood, 2018-09, Vol.132 (13), p.1365-1371

2018

Volltextzugriff (PDF)

Left Ventricular Myocardial Strain by Three-Dimensional Speckle-Tracking Echocardiography in Healthy Subjects: Reference Values and Analysis of Their Physiologic and Technical Determinants

Journal of the American Society of Echocardiography, 2014-08, Vol.27 (8), p.858-871.e1

2014

Volltextzugriff (PDF)

A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation

PloS one, 2015-12, Vol.10 (12), p.e0145318-e0145318

2015

Volltextzugriff (PDF)

Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study

International journal of cardiology, 2017-12, Vol.249, p.198-203

2017

Volltextzugriff (PDF)

Different safety profiles of oral anticoagulants in very elderly non-valvular atrial fibrillation patients. A retrospective propensity score matched cohort study

International journal of cardiology, 2018-08, Vol.265, p.103-107

2018

Volltextzugriff (PDF)

Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case‐control study

Cardiovascular therapeutics, 2018-10, Vol.36 (5), p.e12458-n/a

2018

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(44)
Berichte
(1)

Sprache

Englisch
(45)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(36)
Science & Technology
(32)
Life Sciences & Biomedicine
(31)
Female
(26)
Male
(23)
Cardiovascular System & Cardiology
(20)
Aged
(16)
Middle Aged
(15)
Thrombosis
(15)
Adult
(14)
Hematology
(14)
Risk Factors
(12)
Anticoagulants - Adverse Effects
(11)
Peripheral Vascular Disease
(11)
Cardiac & Cardiovascular Systems
(10)
Aged, 80 And Over
(9)
Antiphospholipid Syndrome - Immunology
(9)
Beta 2-Glycoprotein I - Immunology
(9)
Hemorrhage - Chemically Induced
(9)
Lupus Anticoagulant
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk

Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile

APS - Diagnostics and challenges for the future

Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs)

Laboratory testing for antiphospholipid syndrome

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)

Antiphospholipid syndrome: critical analysis of the diagnostic path

Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study

Correct laboratory approach to APS diagnosis and monitoring

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles

458Real world persistence with direct oral anticoagulants in anticoagulation naive patients with atrial fibrillation

Antiphospholipid syndrome: antibodies to Domain 1 of [beta]2-glycoprotein 1 correctly classify patients at risk

Quantitative analysis of mitral valve geometry by transthoracic three-dimensional echocardiography: accuracy, feasibility, reproducibility and reference values

Long-term use of vitamin K antagonists in patients with atrial fibrillation and cancer incidence: a pharmaco-epidemiological study

Oral Abstract session New insights in heart muscle diseases: 13/12/2013, 16:30-18:00 Location: Bursa

Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

Left Ventricular Myocardial Strain by Three-Dimensional Speckle-Tracking Echocardiography in Healthy Subjects: Reference Values and Analysis of Their Physiologic and Technical Determinants

A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation

Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study

Different safety profiles of oral anticoagulants in very elderly non-valvular atrial fibrillation patients. A retrospective propensity score matched cohort study

Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case‐control study

Suchergebnisse filtern